Related Experiment Video

Updated: Aug 1, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

458

Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy

Guang-Long Ma1, Wei-Feng Lin2,3

  • 1Faculty of Medicine, Centre for Cancer Immunology, University of Southampton, Southampton, SO16 6YD, UK.

Military Medical Research
|April 27, 2023
PubMed

Insights

Liposomal nanomedicine enhances immune checkpoint blockade (ICB) therapy for cancer by improving drug delivery and reducing side effects. This approach shows promise for increasing patient response rates to ICB treatments.

Area of Science:

  • Oncology
  • Nanotechnology
  • Immunotherapy

Background:

  • Immune checkpoint blockade (ICB) therapy is a successful cancer treatment, but limited patient response and immune-related adverse events (irAEs) remain challenges.
  • Nanotechnology offers potential solutions for improving ICB delivery, tumor penetration, and mitigating irAEs.

Purpose of the Study:

  • To review recent advancements in utilizing liposomal nanomedicine for enhancing ICB therapy.
  • To explore how nanotechnology, particularly liposomes and exosome-inspired vesicles, can improve ICB efficacy and safety.

Main Methods:

  • Literature review of studies combining ICB with liposomal nanomedicine.
  • Analysis of nanotechnology applications for improved drug delivery and reduced toxicity in cancer immunotherapy.

Main Results:

  • Liposomal nanomedicine demonstrates potential for enhanced tumor targeting and deeper tissue penetration of ICB agents.
  • Emerging applications include exosomes and inspired nano-vesicles for improved ICB delivery and reduced irAEs.

Conclusions:

  • Combining ICB with liposomal nanomedicine represents a promising strategy to overcome current limitations in cancer immunotherapy.
  • Further research into nanomedicine-based ICB delivery systems could significantly improve treatment outcomes and patient safety.
Keywords:
ExosomeImmune checkpoint blockade (ICB)Liposome

More Related Videos

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.0K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
593
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K